Page 49 - Comprehensive treatment of patients with glucocorticoid-dependent severe asthma

47. Comhair SA, Gaston BM, Ricci KS, et al. Detrimental Effects of Environmental Tobacco Smoke in Relation to Asthma Severity. PLoS One 2011;6:e18574.
48. Siroux V, Pin I, Oryszczyn MP, et al. Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma. Eur Respir J 2000;15:470-7.
49. Livingston E, Thomson NC, Chalmers GW. Impact of smoking on asthma therapy: a critical review of clinical evidence. Drugs 2005;65:1521-36.
50. Ricciardolo FL, Di Stefano A. Corticosteroid resistance in smokers with asthma. Am J Respir Crit Care Med 2004;169:1252-3.
51. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J 2004;24:822- 33.
52. Chaudhuri R, Livingston E, McMahon AD, et al. Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am J Respir Crit Care Med 2006; 174:127-33.
53. Rayens MK, Burkhart PV, Zhang M, et al. Reduction in asthma-related emergency department visits after implementation of a smoke-free law. J Allergy Clin Immunol 2008; 122:537-41.
54. Mackay D, Haw S, Ayres JG, et al. Smoke-free legislation and hospitalizations for childhood asthma. N Engl J Med 2010;363:1139-45.
55. Stenfors N, Nordenhall C, Salvi SS, et al. Different airway inflammatory responses in asthmatic and healthy humans exposed to diesel. Eur Respir J 2004;23:82-6.
56. Avol EL, Gauderman WJ, Tan SM, et al. Respiratory effects of relocating to areas of differing air pollution levels. Am J Respir Crit Care Med 2001;164:2067-72.
57. Bayer-Oglesby L, Grize L, Gassner M, et al. Decline of ambient air pollution levels and improved respiratory health in Swiss children. Environ Health Perspect 2005;113:1632-7.
58. Renzetti G, Silvestre G, D’Amario C, et al. Less air pollution leads to rapid reduction of airway inflammation and improved airway function in asthmatic children. Pediatrics 2009; 123:1051-8.
59. Adams NP, Bestall JC, Jones P, et al. Fluticasone at different doses for chronic asthma in adults and children. Cochrane Database Syst Rev 2008;(4):CD003534.
60. Reddel HK, Jenkins CR, Marks GB, et al. Optimal asthma control, starting with high doses of inhaled budesonide. Eur Respir J 2000;16:226-35.
61. Tayab ZR, Fardon TC, Lee DK, et al. Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoate. Br J Clin Pharmacol 2007;64:698-705.
62. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med 1999;159:941-55.
63. Lipworth BJ. The comparative safety/efficacy ratio of HFA-BDP. Respir Med 2000;94 Suppl D:S21-S26.
64. Mortimer KJ, Tata LJ, Smith CJ, et al. Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study. Thorax 2006;61:405-8.
65. Szefler SJ, Martin RJ, King TS, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002;109:410-8.
66. Tattersfield AE, Harrison TW, Hubbard RB, Mortimer K. Safety of inhaled corticosteroids. Proc Am Thorac Soc 2004;1:171-5.
67. Hall IP. The beta-agonist controversy revisited. Lancet 2004;363:183-4.
68. Tattersfield AE. Current issues with beta2-adrenoceptor agonists: historical background. Clin Rev Allergy Immunol 2006;31:107-18.
69. Sears MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990;336:1391-6.
70. Suissa S, Ernst P, Boivin JF, et al. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 1994;149:604-10.
71. Drazen JM, Israel E, Boushey HA, et al. Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. N Engl J Med 1996;335:841-7.
72. Wahedna I, Wong CS, Wisniewski AF, et al. Asthma control during and after cessation of regular beta 2-agonist treatment. Am Rev Respir Dis 1993;148:707-12.
Current treatment of severe asthma
47
2